A US study looking at the natural history and growth parameters of small, low-risk papillary thyroid cancers supports active surveillance as a management option. READ MORE
Clinical trial results have shown that treatment with nivolumab may be the best choice for patients with head and neck cancer.
A US study looking at the natural history and growth parameters of small, low-risk papillary thyroid cancers supports active surveillance as a management option.
Most people diagnosed with cancer want to start treatment as soon as possible, for fear that delaying care will allow their tumor to grow out of control.
A recent study evaluated survival outcomes after adhering to the NCCN guidelines for time to initiation of postoperative radiation therapy in patients with head and neck squamous cell carcinoma.
A recent study showed that female patients with locally advanced esophageal cancer who are treated with chemotherapy and radiotherapy before surgery are more likely to respond favorably than male patients.
Research in Review
Researchers have identified five quality metrics to help improve head and neck cancer care.
An immunotherapy agent drastically improved patient-reported quality of life in short and long-term analyses compared with conventional chemotherapy for patients with head and neck cancer.
A recent study suggests that immunotherapies targeting both PD-L1 and PD-L2 may enhance response rates for patients with head and neck squamous cell carcinoma.
Although HPV vaccine reduces the rate of oral HPV infection, the vaccine is still underutilized among teens and young adults.
The National Comprehensive Cancer Network has updated their guidelines for central nervous system cancers to include new systemic therapies for the treatment of brain metastases.